Contralateral tumors in animals whose primary tumor had been treated with Ad-p53 alone showed significantly delayed tumor growth (p = 0.046) compared to the growth rate of the primary tumors treated with anti-PD-1 alone. Here, TP53 is linked to neoplasm.